FDA Declines to Approve of Epinephrine Alternative to EpiPen, Requests Further Study
The FDA's announcement requesting further study represents a step back in the process of 'neffy' becoming the first needle-free nasal spray epinephrine alternative.
Richard Lowenthal Grossig David Dworaczyk Advisory Committee Votes In Support Of Favorable Allergy Drug Advisory Committee Drug Administration Advisory Committee
Source: hcplive.com